Detection and localization of prostate cancer: Correlation of 11C-choline PET/CT with histopathologic step-section analysis

Journal of Nuclear Medicine

Volumn 46, Issue 10, 2005, Pages 1642-1649

  Farsad, Mohsen ^a   Schiavina, Riccardo ^b   Castellucci, Paolo ^a   Nanni, Cristina ^a   Corti, Barbara ^b   Martorana, Giuseppe ^b   Canini, Romeo ^b   Grigioni, Walter ^b   Boschi, Stefano ^a   Marengo, Mario ^a   Pettinato, Cinzia ^a   Salizzoni, Eugenio ^b   Monetti, Nino ^a   Franchi, Roberto ^a   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

11C choline PET CT; Prostate cancer; Radionuclide imaging; Tumor localization

Indexed keywords

CARBON 11; CHOLINE C 11; UNCLASSIFIED DRUG; CHOLINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; CANCER STAGING; FEMALE; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICS;

AGED; CHOLINE; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644673784     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6.630 men. J Urol. 1994;15:1283-1290.
2. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol. 1999;162:293-306.
3. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a pro state-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004 27;350:2239-2246.
4. Lujan M, Paez A, Miravalles E. Prostate cancer detection is also relevant in low prostate specific antigen ranges. Eur Urol. 2004;45:155-159.
5. Sedelaar JP, Vijverberg PL, De Reijke TM, et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol. 2001;40:275-284.
6. Chang JJ, Shinohara K, Bhargava V, et al. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol. 1998;160:2111-2114.
7. Beerlage HP, De Reijke TM, de la Rosette JJ. Considerations regarding prostate biopsies. Eur Urol. 1998;34:303-312.
8. Bartolozzi C, Menchi I, Lencioni R, et al. Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens. Eur Radiol. 1996;6:339-345.
9. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 1995;195:385-390.
10. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localisation of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000;164:400-404.
11. Coakley E, Qayyum A, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol. 2003;170(suppl):S69- S76.
12. Effert PJ, Bares R, Handt S, et al. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18 fluorine-labeled deoxyglucose. J Urol. 1996;155:994-998.
13. Liu IJ, Zafar MB, Lai YH, et al. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology. 2001;57:108-111.
14. 11C] acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med. 2002;29:1492-1495.
15. 11C]acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186.
16. 11C-methionine positron emission tomography. J Urol. 2005;173:66-69.
17. Kwee SA, Coel MN, Lim J, et al. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol. 2005;173:252-255.
18. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990-995.
19. Kotzerke J, Prang J, Neumaier B, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med. 2000;27:1415-1419.
20. 11C] choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging. 2003;31:317-324.
21. 11C-choline positron emission tomography. Eur Urol. 2002;42:18-23.
22. Yoshida S, Nakagomi K, Goto S, et al. C-Choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urol Int. 2005;74:214-220.
23. 11C]choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging. 2005;32:668-673.
24. Gore JL, Shariat SE, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165:1554-1559.
25. 11C] choline. J Labelled Compds Radiopharm. 2000;49:195-203.
26. Townsend DW, Beyer T. A combined PET/CT scanner: the path to true image fusion. Br J Radiol. 2002;75:S24-S30.
27. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200-1209.
28. 11C-choline PET: first clinical experience. Eur J Nucl Med. 2002;29:1283-1288.
29. Sakr WA, Grignon DJ. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate. Anal Quant Cytol Histol. 1998;20:417-423.
30. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004;17:360-379.